Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02933892 · ClinicalTrials.gov registry record · Phase 4
Benefit of Transradial Approach in Chronic Kidney Disease Population Undergoing Cardiac Catheterization
A Phase 4 study, sponsored by Texas Tech University Health Sciences Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 39
- Enrollment target
NCT02933892 is a Phase 4 study that has completed, run by Texas Tech University Health Sciences Center. The registered enrollment target is 39 participants.
The verdict
NCT02933892, a Phase 4 study, has completed, sponsored by Texas Tech University Health Sciences Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 39 participants
- Enrollment target
Study Summary
The investigators will conduct a randomized controlled trial that aims to compare the incidence of contrast-induced nephropathy between transradial- and transfemoral-access cardiac catheterization.
Interventions
- PROCEDURE Cardiac Catheterization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2016-10 |
| Est. Completion | 2024-08-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02933892
The ClinicalTrials.gov registry entry for NCT02933892 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Tech University Health Sciences Center, which has 76 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cardiac Catheterization is the first listed.
NCT02933892 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02933892 about?
NCT02933892 is a clinical study titled "Benefit of Transradial Approach in Chronic Kidney Disease Population Undergoing Cardiac Catheterization". The investigators will conduct a randomized controlled trial that aims to compare the incidence of contrast-induced nephropathy between transradial- and transfemoral-access cardiac catheterization.
What is the current status of trial NCT02933892?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 39 participants. The study started on 2016-10. Estimated completion is 2024-08-30.
What interventions are being tested in trial NCT02933892?
The interventions under investigation include: Cardiac Catheterization (PROCEDURE).
Who is sponsoring clinical trial NCT02933892?
This trial is sponsored by Texas Tech University Health Sciences Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.